BioCentury
ARTICLE | Company News

Nucryst management update

February 2, 2009 8:00 AM UTC

Nucryst Pharmaceuticals Corp. (NASDAQ:NCST, TSX:NCS), Princeton, N.J. Business: Dermatology, Autoimmune, Gastrointestinal Resigned: Thomas Gardner as president, CEO and chairman; David Holtz will serv...